Article Versions Notes

Hahn F, Wangen C, Häge S, Herrmann L, Herrmann A, Tsogoeva SB, Marschall M. The Trimeric Artesunate Analog TF27, a Broadly Acting Anti-Infective Model Drug, Exerts Pronounced Anti-SARS-CoV-2 Activity Spanning Variants and Host Cell Types. Pharmaceutics. 2023; 15(1):115. https://doi.org/10.3390/pharmaceutics15010115

Hahn, Friedrich, Christina Wangen, Sigrun Häge, Lars Herrmann, Alexandra Herrmann, Svetlana B. Tsogoeva, and Manfred Marschall. 2023. "The Trimeric Artesunate Analog TF27, a Broadly Acting Anti-Infective Model Drug, Exerts Pronounced Anti-SARS-CoV-2 Activity Spanning Variants and Host Cell Types" Pharmaceutics 15, no. 1: 115. https://doi.org/10.3390/pharmaceutics15010115

Hahn, F., Wangen, C., Häge, S., Herrmann, L., Herrmann, A., Tsogoeva, S. B., & Marschall, M. (2023). The Trimeric Artesunate Analog TF27, a Broadly Acting Anti-Infective Model Drug, Exerts Pronounced Anti-SARS-CoV-2 Activity Spanning Variants and Host Cell Types. Pharmaceutics, 15(1), 115. https://doi.org/10.3390/pharmaceutics15010115